| For: | Grey N, Silosky M, Lieu CH, Chin BB. Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors. World J Gastroenterol 2022; 28(17): 1768-1780 [PMID: 35633909 DOI: 10.3748/wjg.v28.i17.1768] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i17/1768.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Meisam Samadzadeh, Arezoo Khosravi, Atefeh Zarepour, Ghazaleh Jamalipour Soufi, Ali Hekmatnia, Ali Zarrabi, Siavash Iravani. Molecular imaging using (nano)probes: cutting-edge developments and clinical challenges in diagnostics. RSC Advances 2025; 15(30) doi: 10.1039/D5RA03927D
|
| 3 |
Caitlin McCutcheon, Zachary Lawrence, Marie James, Taryn Palluccio, Maha Chowdhury, Pradeep K. Singh, Kelly Orcutt, Shil Patel. Cross-Species Quantitative Benchmarking of SSTR2 Radioligands in Fresh-Frozen Brain Sections: An Adaptable Framework for Radiopharmaceutical Development. Molecular Imaging and Biology 2026; doi: 10.1007/s11307-026-02113-9
|
| 4 |
Haiqiong Zhang, Meixi Liu, Ximin Shi, Jiangyu Ma, Chao Ren, Zhenghai Huang, Ying Wang, Hongli Jing, Li Huo. Feasibility of a deep-inspiration breath-hold [18F]AlF-NOTA-LM3 PET/CT imaging on upper-abdominal lesions in NET patients: in comparison with respiratory-gated PET/CT. EJNMMI Physics 2024; 11(1) doi: 10.1186/s40658-024-00677-5
|
| 5 |
Qian-Qian Liu, Zi-Kai Dong, Yong-Fei Wang, Wei-Lin Jin. Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies. Military Medical Research 2025; 12(1) doi: 10.1186/s40779-025-00661-9
|
| 6 |
Drishty Satpati. Cancer Targeting Radiopeptidomimetics in Molecular Nuclear Medicine. Molecular Pharmaceutics 2025; 22(8) doi: 10.1021/acs.molpharmaceut.4c01180
|
| 7 |
Wajahat Khatri, Ergi Spiro, Amanda Henderson, Steven P. Rowe, Lilja B. Solnes. Gastro-Entero-Pancreatic Tumors. PET Clinics 2023; 18(2) doi: 10.1016/j.cpet.2022.11.007
|
| 8 |
Habibollah Dadgar, Esmail Jafari, Hojjat Ahmadzadehfar, Seyed Javad Rekabpour, Mohammad Reza Ravanbod, Mohammadreza Kalantarhormozi, Iraj Nabipour, Majid Assadi. Feasibility and therapeutic potential of the 68Ga/177Lu-DOTATATE theranostic pair in patients with metastatic medullary thyroid carcinoma. Annales d'Endocrinologie 2023; 84(1) doi: 10.1016/j.ando.2022.08.001
|
| 9 |
Yinting Hu, Yang Chen, Jiamin Zhu, Kun Qian, Danyi Guo, Baozhen Zeng, Peng Wang, Dan Tian, Hui Yuan, Lei Jiang. Synthesis, Preclinical Investigations, and Pilot Clinical Imaging Studies of 68Ga-Labeled Peptide-Derived c-Met-Targeted PET Probes. Journal of Medicinal Chemistry 2026; 69(7) doi: 10.1021/acs.jmedchem.5c03596
|
| 10 |
Neeraj Kumari, Pablo Hoffmann, Laura Reichl, Maximilian Schmutz, Nina Fischer, Thi Tuong Vi Dang, Fulvia Ferrazzi, Pascal Johann, Michaela Kuhlen, Constantin Lapa, Rainer Claus. Epigenetic Dysregulation of Somatostatin Receptors (SSTR) 1–5 and Therapeutic Implications in Neuroendocrine and Non‐Neuroendocrine Malignancies. International Journal of Cancer 2026; doi: 10.1002/ijc.70635
|
| 11 |
Chang-Jiang Liu, Hua-Jun Yang, Yan-Chun Peng, De-Yu Huang. Pancreatic neuroendocrine tumor detected by technetium-99m methoxy-2-isobutylisonitrile single photon emission computed tomography/computed tomography: A case report. World Journal of Clinical Cases 2023; 11(12): 2825-2831 doi: 10.12998/wjcc.v11.i12.2825
|